| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/18/2013 | US20130184294 Pyrimidones for Treatment of Potassium Channel Related Diseases |
| 07/18/2013 | US20130184293 Compositions and methods for treating diabetes and neuropsychological dysfunction |
| 07/18/2013 | US20130184291 Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsuflanyl)phenyl]piperazine |
| 07/18/2013 | US20130184290 Self-emulsifying formulations and methods of use thereof |
| 07/18/2013 | US20130184287 Indazole compounds and their uses |
| 07/18/2013 | US20130184284 Diaminocyclohexane compounds and uses thereof |
| 07/18/2013 | US20130184283 Method for treating psoriasis |
| 07/18/2013 | US20130184282 Ip receptor agonist heterocyclic compounds |
| 07/18/2013 | US20130184281 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 07/18/2013 | US20130184273 Bicyclic pyrimidines |
| 07/18/2013 | US20130184272 Diabetes therapeutic agent |
| 07/18/2013 | US20130184270 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations |
| 07/18/2013 | US20130184268 2-(r2-thio)-10-[3-(4-r1-piperazin-1-yl) propyl]-10h-phenothiazine for treating a beta-amyloidopathy or an alpha-synucleopathy, and method for the diagnosis or prediagnosis thereof |
| 07/18/2013 | US20130184263 Derivatives of Betulin |
| 07/18/2013 | US20130184262 Diaminocyclohexane compounds and uses thereof |
| 07/18/2013 | US20130184260 Pyridazinone derivatives |
| 07/18/2013 | US20130184258 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 07/18/2013 | US20130184252 Dihydropyrrolonaphthyridinone compounds as inhibitors of jak |
| 07/18/2013 | US20130184249 Pyrrolidine derivatives |
| 07/18/2013 | US20130184247 Method for preparation of nicotinic acid copper chloride complex, and its pharmaceutical uses |
| 07/18/2013 | US20130184246 Method for treating fatty liver diseases, in particular non-alcoholic steatohepatitis |
| 07/18/2013 | US20130184245 Endometriosis treatment |
| 07/18/2013 | US20130184243 Compositions of alkylating agents and methods of treating skin disorders therewith |
| 07/18/2013 | US20130184242 Pharmaceutical Composition for Topical Application |
| 07/18/2013 | US20130184239 Combination of siloxane and active ingredient for treating dental disorder |
| 07/18/2013 | US20130184234 Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions |
| 07/18/2013 | US20130184232 Methods for administering dpd inhibitors in combination with 5-fu and 5-fu prodrugs |
| 07/18/2013 | US20130184231 Organ arrest, protection and preservation |
| 07/18/2013 | US20130184230 Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine |
| 07/18/2013 | US20130184228 Muscadine compositions with anti-oxidant activity |
| 07/18/2013 | US20130184227 Cytochrome P450 2C9 Inhibitors |
| 07/18/2013 | US20130184223 Methods and compositions related to modulating autophagy |
| 07/18/2013 | US20130184220 Treatment of abnormal or excessive scars |
| 07/18/2013 | US20130184218 Targeted Osmotic Lysis of Cancer Cells |
| 07/18/2013 | US20130184217 Targeting micrornas for the treatment of fibrosis |
| 07/18/2013 | US20130184214 Pharmaceutical compositions and methods |
| 07/18/2013 | US20130184211 Inhibiting binding of fgf23 to the binary fgfr-klotho complex for the treatment of hypophosphatemia |
| 07/18/2013 | US20130184206 Selective androgen receptor modulators (SARMs) and uses thereof |
| 07/18/2013 | US20130184205 Antitumor combinations containing a vegf-inhibiting agent and 5fu or a derivative thereof |
| 07/18/2013 | US20130184204 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| 07/18/2013 | US20130184198 Pulmonary Surfactant Formulations |
| 07/18/2013 | US20130183693 Method and kit for detecting the early onset of renal tubular cell injury |
| 07/18/2013 | US20130183395 Compositions comprising botanicals, including the use and method of use thereof |
| 07/18/2013 | US20130183388 Novel IDO Inhibitors and Methods of Use Thereof |
| 07/18/2013 | US20130183387 Methods for treating pustular conditions of the skin |
| 07/18/2013 | US20130183384 Immediate release multi unit pellet system |
| 07/18/2013 | US20130183383 Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same |
| 07/18/2013 | US20130183381 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitor |
| 07/18/2013 | US20130183363 Prevention of indwelling device related infection: composition and methods |
| 07/18/2013 | US20130183359 Polymeric compositions containing ir-emitting/absorbing additives and shaped articles comprised thereof |
| 07/18/2013 | US20130183353 Low dosage forms of risedronate or its salts |
| 07/18/2013 | US20130183351 Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products |
| 07/18/2013 | US20130183348 Inhibitor of HMGB Protein-Mediated Immune Response Activation, and Screening Method |
| 07/18/2013 | US20130183339 Methods and compositions involving immunostimulatory oligodeoxynucleotides |
| 07/18/2013 | US20130183325 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations |
| 07/18/2013 | US20130183318 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 07/18/2013 | US20130183303 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |
| 07/18/2013 | US20130183302 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |
| 07/18/2013 | US20130183301 Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancer |
| 07/18/2013 | US20130183300 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 07/18/2013 | US20130183298 Methods of Treating Hepatitis With Anti-TNF alpha Antibodies |
| 07/18/2013 | US20130183297 Method of treating cancers and a pharmaceutical composition that may be used in practicing said method |
| 07/18/2013 | US20130183295 Therapy-enhancing glucan |
| 07/18/2013 | US20130183289 Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml) |
| 07/18/2013 | US20130183285 Methods for accelerating the healing of connective tissues injuries and disorders |
| 07/18/2013 | US20130183281 Methods and compositons for cell-proliferation-related disorders |
| 07/18/2013 | US20130183277 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 07/18/2013 | US20130183275 Novel Use of Cryptotanshinone |
| 07/18/2013 | US20130183269 Hepatitis C Virus Inhibitors |
| 07/18/2013 | US20130183268 Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 07/18/2013 | US20130183267 Cyclosporin analogues for preventing or treating hepatitis c infection |
| 07/18/2013 | US20130183266 Compounds and methods for the treatment or prevention of flavivirus infections |
| 07/18/2013 | US20130183264 Antagonists of IL-6 to raise albumin and/or lower crp |
| 07/18/2013 | US20130183263 Pharmaceutical compositions and methods |
| 07/18/2013 | US20130183257 Compositions and methods for improving skin appearance |
| 07/18/2013 | US20130183256 Silicone scar treatment preparation |
| 07/18/2013 | US20130183255 Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same |
| 07/18/2013 | US20130183254 Methods and compositions for promoting hair growth |
| 07/18/2013 | US20130183251 Penetrating pharmaceutical foam |
| 07/18/2013 | US20130181107 Furnace mount and method of installation |
| 07/18/2013 | DE102012000786A1 Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung, enthaltend den Wirkstoff Rasagilin A process for preparing a solid pharmaceutical composition containing the active substance rasagiline |
| 07/18/2013 | CA2860999A1 Synthesis of polyhydroxy chromenone compounds and their anti-tumor effects |
| 07/18/2013 | CA2860995A1 Pharmaceutical compositions and methods for their preparation |
| 07/18/2013 | CA2860973A1 A method for producing stable, amorphous hybrid nanoparticles comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component |
| 07/18/2013 | CA2860952A1 Fixed dose combination therapy of parkinson's disease |
| 07/18/2013 | CA2860932A1 A pharmaceutical composition comprising stable, amorphous hybrid nanopraticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component |
| 07/18/2013 | CA2860855A1 Substituted annulated pyrimidines and triazines, and use thereof |
| 07/18/2013 | CA2860847A1 Substituted, annulated imidazoles and pyrazoles, and use thereof |
| 07/18/2013 | CA2860842A1 Methods of treating or preventing insulin resistance and associated diseases and conditions |
| 07/18/2013 | CA2860826A1 Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase |
| 07/18/2013 | CA2860808A1 Benzamide derivatives as modulators of the follicle stimulating hormone |
| 07/18/2013 | CA2858043A1 Oral care compositions |
| 07/18/2013 | CA2857521A1 Leukotriene b4 antagonist compound |
| 07/18/2013 | CA2857400A1 Method for treating breast cancer |
| 07/18/2013 | CA2857207A1 Topical pharmaceutical compositions comprising bexarotene and a corticosteroide |
| 07/18/2013 | CA2856204A1 Heterocyclic derivatives as trace amine associated receptors (taars) |
| 07/18/2013 | CA2852220A1 Cartridge and method for increasing myocardial function |
| 07/18/2013 | CA2852173A1 Macrocyclic amides as protease inhibitors |
| 07/18/2013 | CA2832596A1 Taxane and abeo-taxane analogs |
| 07/18/2013 | CA2803240A1 Sodium ascorbate stimulation of elastogenesis |